Matches in Wikidata for { <http://www.wikidata.org/entity/Q91031158> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q91031158 description "2019 թվականի հունվարի 11-ին հրատարակված գիտական հոդված" @default.
- Q91031158 description "article scientifique publié en 2019" @default.
- Q91031158 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91031158 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91031158 description "scientific article published on 11 January 2019" @default.
- Q91031158 description "wetenschappelijk artikel" @default.
- Q91031158 description "наукова стаття, опублікована 11 січня 2019" @default.
- Q91031158 name "Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment" @default.
- Q91031158 name "Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment" @default.
- Q91031158 type Item @default.
- Q91031158 label "Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment" @default.
- Q91031158 label "Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment" @default.
- Q91031158 prefLabel "Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment" @default.
- Q91031158 prefLabel "Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment" @default.
- Q91031158 P1433 Q91031158-649C28EC-A972-4990-9AA5-D210183F376B @default.
- Q91031158 P1476 Q91031158-56F9DEF0-31EB-4E8F-9719-6C2BD6BDDA71 @default.
- Q91031158 P2093 Q91031158-94F7CB01-23A5-4A9E-A4E6-057FD5A24E90 @default.
- Q91031158 P2093 Q91031158-C131BF71-D55A-474E-A381-70D7010FF61B @default.
- Q91031158 P2093 Q91031158-CF42156B-6DD1-473B-879F-6C6C8E000EE8 @default.
- Q91031158 P2093 Q91031158-D72D071D-066F-4EBA-8880-4019CE94408A @default.
- Q91031158 P2093 Q91031158-ECFF95EC-407A-45E6-872C-4F7A6CD7A2A3 @default.
- Q91031158 P304 Q91031158-121F2510-5A49-45D7-AE81-DDDA9812407F @default.
- Q91031158 P31 Q91031158-5E95E8DB-A35F-4968-8E0E-855C682CC42B @default.
- Q91031158 P356 Q91031158-0E9C78EA-9022-4A3A-9029-D7D2AEB15770 @default.
- Q91031158 P433 Q91031158-49FB87E4-02E8-4B24-B5C5-4BF7EB2C182B @default.
- Q91031158 P478 Q91031158-6430B9CB-11D3-4714-A8A6-5880A2F9504F @default.
- Q91031158 P50 Q91031158-7572634A-A679-42C9-B0C2-CD1C0668289F @default.
- Q91031158 P50 Q91031158-A06C2788-C921-4E1B-81C8-C7822E614A90 @default.
- Q91031158 P577 Q91031158-E992BAC2-4369-4FB1-8458-14D62006BC24 @default.
- Q91031158 P698 Q91031158-AFBE78E7-AA28-4DE3-8CBB-A5B763D14594 @default.
- Q91031158 P921 Q91031158-08499BAD-4E15-451A-8FEB-36FD851CCF8C @default.
- Q91031158 P921 Q91031158-21E16C92-9A3B-4BD9-8DDD-72CB426F3CEA @default.
- Q91031158 P356 J.AUTREV.2018.11.002 @default.
- Q91031158 P698 30639638 @default.
- Q91031158 P1433 Q15754966 @default.
- Q91031158 P1476 "Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment" @default.
- Q91031158 P2093 "Alessandra Bettiol" @default.
- Q91031158 P2093 "Domenico Prisco" @default.
- Q91031158 P2093 "Elena Silvestri" @default.
- Q91031158 P2093 "Gianfranco Vitiello" @default.
- Q91031158 P2093 "Paola Parronchi" @default.
- Q91031158 P304 "312-314" @default.
- Q91031158 P31 Q13442814 @default.
- Q91031158 P356 "10.1016/J.AUTREV.2018.11.002" @default.
- Q91031158 P433 "3" @default.
- Q91031158 P478 "18" @default.
- Q91031158 P50 Q61086244 @default.
- Q91031158 P50 Q61163712 @default.
- Q91031158 P577 "2019-01-11T00:00:00Z" @default.
- Q91031158 P698 "30639638" @default.
- Q91031158 P921 Q1996249 @default.
- Q91031158 P921 Q421094 @default.